20 Aug by Vitaliy Dadalyan Loss-Making Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) Expected To Breakeven Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) is possibly approaching a major achievement in its business, so we would…
